National Cancer Action Team

Although the Operating framework for 2012/13, published in November

2011, introduced mandatory currencies for chemotherapy delivery,

there is still no official policy as to whether chemotherapy might come

within the scope of a national tariff.  However, it is reasonable to assume  

that  any  proposed  tariffs  could  be  based,  in  part,  on  the  2009/10  

or 2010/11 Reference Costs collections.

Furthermore,  irrespective  of  developments  in  the  national  tariff,  

expenditure on chemotherapy continues to increase. Government policy

has been to invest in this area as part of its national plan for cancer, with

additional funding earmarked for drugs since the general election of

2010.  For these reasons, the quality and robustness of activity recording

and costing remains a key issue for chemotherapy services.

Click here for a copy of the report.

• previous
• 34 of 45
• next